Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01818739 · ClinicalTrials.gov registry record · NA
Lymph Node Mapping in Patients With Endometrial Cancer
A NA study of Endometrial Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 2
- Study locations
NCT01818739 is a NA study of Endometrial Cancer that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 204 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01818739, a NA study of Endometrial Cancer, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.
Conditions Studied
Interventions
- PROCEDURE sentinel lymph node biopsy
- DRUG indocyanine green solution
- PROCEDURE sentinel lymph node detection
- DRUG isosulfan blue
Study Locations (2)
Connecticut
- Smilow Cancer Hospital at Yale New Haven - New Haven
Ohio
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2013-03 |
| Est. Completion | 2017-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01818739
The ClinicalTrials.gov registry entry for NCT01818739 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (61% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 4 interventions - of which sentinel lymph node biopsy is the first listed.
NCT01818739 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Ohio.
Frequently Asked Questions
What is clinical trial NCT01818739 about?
NCT01818739 is a clinical study titled "Lymph Node Mapping in Patients With Endometrial Cancer". This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.
What is the current status of trial NCT01818739?
This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2013-03. Estimated completion is 2017-03-31.
What conditions does trial NCT01818739 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT01818739?
The interventions under investigation include: sentinel lymph node biopsy (PROCEDURE), indocyanine green solution (DRUG), sentinel lymph node detection (PROCEDURE), isosulfan blue (DRUG).
Who is sponsoring clinical trial NCT01818739?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01818739 being conducted?
This trial has 2 study locations across Connecticut, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.